The American Journal of Managed Care: Polypharmacy Nearly Doubles Health Care Expenditures Among Older Patients With CVD Polypharmacy was associated with a nearly doubled increase in health care expenditures and a tripled increase in pharmacy expenditures among older patients with cardiovascular diseases (CVD). Yahoo Finance: RazorMetrics Launches Polypharmacy Solution to Reduce Cost and Medication Burden that Affects 24% of US Working Population AUSTIN, Texas, Jan. 13, 2025 /PRNewswire/ -- RazorMetrics, a leading innovator in pharmacy technology solutions, today announced the launch of its Polypharmacy Solution, designed to tackle the growing ...

Understanding the Context

RazorMetrics Launches Polypharmacy Solution to Reduce Cost and Medication Burden that Affects 24% of US Working Population Global antipsychotic polypharmacy use increased significantly from 1970 to 2023, with 25% of antipsychotic users receiving multiple prescriptions, new research shows. Antipsychotic polypharmacy was ... In patients with acute HF, polypharmacy is common and associated with multimorbidity and older age. Polypharmacy is common globally among patients with acute heart failure (HF) and is associated with ...

Key Insights

Scientific Research Publishing: Review of Safety Management and Nursing Strategies for Polypharmacy in Older Adults () With accelerated population ageing and the growing prevalence of multimorbidity, polypharmacy in older adults has become a major challenge for medication safety and treatment effectiveness. Review of Safety Management and Nursing Strategies for Polypharmacy in Older Adults () This week, Bobbi Conner talks with MUSC's Dr. Gregory Fear about the issues and challenges of polypharmacy in the older adult years. Medscape: Polypharmacy in Patients With Systemic Lupus Erythematosus Primarily Driven by Non-Lupus Drugs More than half of adult patients with systemic lupus erythematosus (SLE) had polypharmacy, defined as the concurrent use of five or more medications, a cross-sectional study found. Polypharmacy was ...

Final Thoughts

Polypharmacy in Patients With Systemic Lupus Erythematosus Primarily Driven by Non-Lupus Drugs